Intermountain Health, a Utah-based, not-for-profit system of 33 hospitals, health plans and a medical group, has launched a new biotechnology company, Culmination Bio, HealthExec reports.
The company will develop an exclusive, anonymized and de-identified intelligence platform that will aim to develop novel clinical insights, discoveries and care processes, according to Intermountain. The precision medicine play will work on a multi-modal intelligence platform that will give customers access to omics-level data and a powerful insights engine for medical research, health data and healthcare services. The aim of the biotech company is to “transform healthcare by providing comprehensive information on patient predisposition to disease, disease prevention and personalized intervention and treatments,” the company said. Read more.
